TSH Biopharm Corporation Limited (TPEX:8432)

Market Cap	2.01B
Revenue (ttm)	1.24B
Net Income (ttm)	114.76M
Shares Out	38.40M
EPS (ttm)	2.98
PE Ratio	17.55
Forward PE	n/a
Dividend	2.12 (4.05%)
Ex-Dividend Date	Jun 16, 2025

Volume	34,019
Average Volume	43,611
Open	52.10
Previous Close	52.20
Day's Range	51.60 - 52.70
52-Week Range	43.00 - 68.20
Beta	0.30
RSI	66.91
Earnings Date	Sep 4, 2025

About TSH Biopharm Corporation

TSH Biopharm Corporation Limited develops and markets pharmaceutical products in Taiwan and Asia. It offers products for cardiovascular, central nervous, gastrointestinal, and others. The company was founded in 1999 and is headquartered in Taipei city, Taiwan. TSH Biopharm Corporation Limited is a subsidiary of TTY Biopharm Company Limited.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1999
• Employees: 76
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 8432

Financial Performance

In 2024, TSH Biopharm Corporation's revenue was 1.12 billion, an increase of 37.59% compared to the previous year's 810.92 million. Earnings were 113.09 million, an increase of 82.44%.